Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06241638Not ApplicableCompleted

Improving HbA1c Levels by Methylcobalamin Vitamin in Diabetic Volunteers

Role: lead

NCT04518930Not ApplicableCompleted

High Fat vs High Protein and Appetite Hormones

Role: lead

NCT06378879Not ApplicableNot Yet Recruiting

Intermittent Boluses Versus Infusion of Propofol During Gastroscopy

Role: lead

NCT03310307Phase 2Completed

Vitamin D3 Treatment and Homocysteine Concentrations Among Overweight Reproductive Women

Role: lead

All 4 trials loaded